CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Cardiomyopathy, Dilated, 1w
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cardiomyopathies
|
0.480 |
GeneticVariation
|
group |
CLINVAR |
|
|
|
Cardiomyopathies
|
0.480 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Hypertrophic Cardiomyopathy
|
0.440 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiomyopathy, Dilated
|
0.160 |
Biomarker
|
group |
HPO |
|
|
|
Dyspnea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lipodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopathy
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neutrophil abnormality
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Endomyocardial Fibrosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Lipoatrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Left ventricular noncompaction
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Keratoderma, Palmoplantar
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscular Dystrophy, Duchenne
|
0.010 |
Biomarker
|
disease |
BEFREE |
These proteins, including vinculin, which was previously reported to be reduced in DMD patient muscles, were normally present on the surface of all dystrophin-deficient fibres.
|
8263549 |
1993 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
The first step of invasion and metastasis is the detachment of cancer cells in the primary tumor, which is mainly controlled by the function in the adherens junction, consisting of E-cadherin associated proteins (E-cadherin, alpha- and beta-catenins, vinculin, alpha-actinin, and actin).
|
8639463 |
1996 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
The first step of invasion and metastasis is the detachment of cancer cells in the primary tumor, which is mainly controlled by the function in the adherens junction, consisting of E-cadherin associated proteins (E-cadherin, alpha- and beta-catenins, vinculin, alpha-actinin, and actin).
|
8639463 |
1996 |
Neoplasm Metastasis
|
0.060 |
Biomarker
|
phenotype |
BEFREE |
The first step of invasion and metastasis is the detachment of cancer cells in the primary tumor, which is mainly controlled by the function in the adherens junction, consisting of E-cadherin associated proteins (E-cadherin, alpha- and beta-catenins, vinculin, alpha-actinin, and actin).
|
8639463 |
1996 |
Obstructive Ureterocele
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To elucidate the role of smooth muscle cell proliferation in late graft failure, specimens from highly stenotic or occluded vein grafts implanted into the arterial circulation for more than 5 years were tested for their expression rate of meta-vinculin.
|
9158163 |
1997 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We quantitatively determined the amounts of laminin, fibronectin, vitronectin, and thrombospondin secreted by these glioma cell lines in vitro, as well as the amount of each of the eight beta integrin subunits and the adhesion complex-related molecules, including talin, vinculin, profilin, zyxin, alpha-actinin, paxillin, and VASP.
|
11746774 |
2001 |